Prediction variables | Risk status | Definition of group | % population | % cases | Risk |
Test sample results | |||||
Questionnaire data only | High | Reports doctor-diagnosed COPD/emphysema or any dyspnoea or smoking >20 years | 54.3 | 87.2 | 13.0 |
Low | Rest of the sample | 45.7 | 12.8 | 2.3 | |
Prebronchodilator PEF and questionnaire data | High | PEF/Ht2 ⩽2.2 | 21.6 | 83.8 | 31.4 |
Low | PEF/Ht2 >2.2 | 78.4 | 16.2 | 1.7 | |
Validation sample results | |||||
Questionnaire data only | High | Reports doctor-diagnosed COPD/emphysema or any dyspnoea or smoking >20 years | 55.4 | 87.5 | 12.6 |
Low | Rest of the sample | 44.6 | 12.5 | 2.2 | |
Prebronchodilator PEF and questionnaire data | High | PEF/Ht2 ⩽2.2 | 21.8 | 83.9 | 30.7 |
Low | PEF/Ht2 >2.2 | 78.2 | 16.1 | 1.6 |
Forced expiratory volume in 1 5 (FEV1) <80% predicted.
*Postbronchodilator FEV1/FVC <LLN.
CART, classification and regression tree modelling; COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; LLN, lower limit of normal; PEF, peak expiratory flow.